Our findings support the growing body of literature suggesting that routine early post-operative Hb monitoring may be redundant in most patients due to the exceedingly low transfusion rate observed (<1%), despite over half of the cohort demonstrating anaemia by standard laboratory thresholds. The gene discussed is GSTM1; the disease is anemia (phenotype).